PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 72: Articles 35501-36000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Cryptogenic cerebral embolism in women taking oral contraceptives.
  2. Cultural factors affecting family planning.
  3. Current problems concerning the use of contraceptive drugs by women. [Problemi attuali sull'impiego dei farmaci contraccettivi nella donna.]
  4. Current safety and status of the oral contraceptives.
  5. Current status of research in contraception.
  6. Cyclic patterns of gonadotrophin, pregnanediol, and corticoid excretion in women on long-term oral contraceptive therapy.
  7. Dahomey. (Family planning)
  8. A Dalkon Shield imbedded in a myoma: case report of an unusual displacement of an intrauterine contraceptive device.
  9. Dana-Super type IUD as a long-term contraceptive. [Das Intrauterinpessar vom Typ DANA-Super als Langzeit-Kontrazeptivum.]
  10. Danazol-testosterone combination: a potentially effective means for reversible male contraception. A preliminary report.
  11. Death of a Dogma? The American Catholic Clergy's Views of Contraception.
  12. Defeat on free contraceptives.
  13. Defining institutional roles in the National Family Planning Program.
  14. Delayed marriage and planned birth: Translation of a Chinese birth control manual.
  15. Delivery of health care services in less developed countries with emphasis on integration of family planning with maternal and child health: a literature search.
  16. Demand for family planning advice among patients in a district maternity hospital.
  17. Demographic explosion: birth control and family planning. [Explosao demografica: controle da natalidade e planejamento familiar.]
  18. Demographic information for medical education in family planning.
  19. Demographic-social and family planning aspects of surgical contraception: focus on countries other than U.S., Puerto Rico and India.
  20. Depo-Provera as long-acting injectable contraceptive.
  21. Depot medroxyprogesterone acetate as a contraceptive. [El acetato de medroxy-progesterona de deposito como anticonceptivo.]
  22. Depot-medroxyprogesterone acetate as a contraceptive agent: return of fertility after discontinuation of use.
  23. Depressed lymphocyte response to P.H.A. in long-term users of oral contraceptives.
  24. Determinants of family planning acceptance in a low socioeconomic group of women.
  25. Development of a community-focused family planning program: agency and interpersonal relations.
  26. Development of a new long acting contraceptive for women.
  27. The development of contraception: psychodynamic considerations.
  28. Development of family planning programmes in the Indian Ocean Region and their demographic impact: An overview.
  29. Development of population/family planning curriculum. (Faculty of Public Health, Mahidol University, Thailand)
  30. Development of public policy on family planning and population in the United States, 1954-1973.
  31. The development of systemic chemical contraceptives.
  32. Device and technic for blocking the uterine tubes - a method for reversible contraceptive sterilization. (Abstract Only)
  33. Diabetogenic effect of contraceptives. [Effet diabetogene des contraceptifs.]
  34. A dialogue with you and me: another way to look at family planning communication.
  35. Die Wirkung der Ovulationshemmer auf das Gametenmaterial. (Actions of steroid contraceptives on gametic material.)
  36. Diethylstilbestrol as a "morning-after" contraceptive.
  37. Dieting, anorexia nervosa and amenorrhoea after oral contraceptive treatment.
  38. Differentials in Philippine contraceptive continuation and pregnancy rates.
  39. Diffusion at micro level: family planning communications to and from Malaysian acceptors.
  40. Direct and indirect financing of family planning programs: project grants and reimbursement mechanisms.
  41. Directions and potentials of contraceptive research.
  42. Disabled children - Free contraception to all? - More liberal liquor laws?
  43. The disparity between who needs and who uses family planning.
  44. Dissecting hematoma of the coronary artery: a possible complication of oral contraceptive therapy.
  45. The distribution and supervision of systemic contraceptives.
  46. Distribution of contraceptives in the commercial sector of Iran.
  47. Distribution of contraceptives in the commercial sector of Korea.
  48. Distribution of contraceptives in the commercial sector of the Philippines.
  49. Distribution of contraceptives in the commercial sector of Venezuela.
  50. Diurnal variation in oral glucose tolerance: insulin and growth hormone changes with special reference to women taking oral contraceptives.
  51. DMPA as an injectable contraceptive: good or bad?
  52. Do oral contraceptives need to be interrupted in order to treat vaginal candidiasis?
  53. Domiciliary family planning and the nurse.
  54. Dominican Republic. (Family planning)
  55. Dr. Mahler: WHO must be the family planning co-ordinator.
  56. Early incidence rates of precancerous cervical lesions in women using contraceptives.
  57. Early postpartum insertion of intrauterine contraceptive device.
  58. East Asia tackles its population problem: population and family planning in nine countries.
  59. Education and family planning.
  60. Education in family planning and maternal and child health.
  61. Educational approach: information education in family planning.
  62. Educational programs for personnel and parents in family planning.
  63. Edward Bliss Foote: pioneer American advocate of birth control.
  64. Effect of an oral contraceptive on NaCl appetite and preference threshold in rats.
  65. Effect of chronic administration of an oral contraceptive on the blood pressure of rats.
  66. Effect of contraceptive pills on sexual activity in the luteal phase of the human menstrual cycle.
  67. Effect of contraceptives on visual field, dark adaptation, and intraocular pressure. [Untersuchungen uber den Einfluss von Kontrazeptiva auf das Gesichtsfeld, die Dunkeladaptation und den intraocularen Druck.]
  68. The effect of different oral contraceptives on carbohydrate metabolism: follow-up study.
  69. The effect of intrauterine contraceptive devices on ovarian and menstrual function in the human.
  70. Effect of oral contraceptive on urinary metabolite excretions after administration of L-tryptophan or L-kynurenine sulfate.
  71. Effect of oral contraceptive steroids upon endogenous ovarian steroid production.
  72. Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women.
  73. The effect of oral contraceptives on biochemistry "normal values".
  74. Effect of oral contraceptives on blood coagulation and liver tests. (Abstract only)
  75. Effect of oral contraceptives on blood vessels and migraine. [Die wirkung von oralen Antikonzeptiva auf Blutgefasse und Migrane.]
  76. Effect of oral contraceptives on carbohydrate metabolism. [Vliyanie oralnykh kontratseptivov na uglevodnyi obmen.]
  77. The effect of oral contraceptives on concentrations of various components of human milk.
  78. The effect of oral contraceptives on serum copper levels in Nigerian women.
  79. Effect of oral contraceptives on the albumin in blood serum. [Einfluss der oralen Kontrazeptiva auf das Eiweissbild im Serum.]
  80. Effect of oral contraceptives on the cotton pellet-induced granuloma in rats.
  81. Effect of oral contraceptives on the thromboelastogram.
  82. Effect of oral contraceptives on thrombocyte function.
  83. The effect of oral contraceptives on Vitamin-B6 status.
  84. Effect of oral steroid contraceptives on mammary fibroadenoma. [Der Einfluss oraler Steroidkontrazeptiva auf das Fibroadenom der Mamma.]
  85. The effect of publicity on contraceptive practice.
  86. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception.
  87. Effect of short term use of oral contraceptives on fibrinolytic activity of the blood.
  88. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol.
  89. The effect of steroidal contraceptives on the reproductive system.
  90. Effect of the contraceptive steroids norethynodrel and mestranol on dental caries activity in young adult female rats.
  91. Effect of the intrauterine contraceptive device on the regeneration of rabbit endometrium.
  92. The effect of the statement by the committee on safety of drugs concerning oral contraceptives containing oestrogens on the contraceptive practices of women attending two family planning clinics.
  93. Effective family planning programs.
  94. Effects of a progestational oral contraceptive on lipids and lipases.
  95. The effects of a sequential type and a progestogen type oral contraceptive on Vitamin A metabolism. (Abstract only)
  96. The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D-beta hydroxybutyrate and triglycerides.
  97. Effects of antibiotics on oestrogen excretion in women taking oral contraceptives. (Abstract only)
  98. Effects of clofibrate and of oral contraceptives on biliary lipid composition and bile acid kinetics in man. (Abstract only)
  99. Effects of contraceptive pill constituents on fetal mouse hearts.
  100. The effects of estrogens, progestogen, oral contraceptives, and intrauterine devices on fasting triglyceride and insulin levels.
  101. Effects of hormonal contraceptives and pregnancy on serum protein pattern.
  102. The effects of long-term administration of oral contraceptives on liver functions. [Vliv dlouhodobeho uzivani peroralnich antikoncepcnich latek na jaterni funkce.]
  103. Effects of oral contraceptives and obesity on carrier tests for phenylketonuria.
  104. Effects of oral contraceptives on anions and cations of human cervical mucus.
  105. Effects of oral contraceptives on free fatty acids of human cervical mucus.
  106. The effects of oral contraceptives on the cytology of the secretory cells of the cervix.
  107. Effects of oral contraceptives on the human menstrual cycle.
  108. Effects of oral contraceptives on the vascular system.
  109. The effects of oral contraceptives on thyroid gland function tests with iodine-131. [Efeitos dos anticoncepcionais orais sobre as provas de funcao tireoidea com o iodine-131.]
  110. Effects of oral contraceptives, estrogens, and progestogens on protein, carbohydrate, and lipid metabolism.
  111. Effects of sex guilt and sexual arousal on the retention of birth control information.
  112. Effects of some contraceptive steroids on serum proteins of women.
  113. Effects of steroid contraceptives on lactation. [El efecto de los contraceptivos esteroides sobre la lactacion.]
  114. The effects of systemic contraceptives.
  115. Efficacy and side effects of modern contraceptives. [Efektywnosc i dzialanie uboczne nowoczesnych srodkow antykoncepcyjnych.]
  116. An effort to strengthen family planning program management in Central America: State I.
  117. Electrocardiogram changes with intrauterine contraceptive device insertion.
  118. Electroencephalogram and contraceptive drugs. [Electrencefalograma e drogas anticoncepcionais.]
  119. Electroencephalographic changes following steroid contraceptives.
  120. Electrophoretic study of serum proteins in women using oral contraceptive for 1 to 3 years.
  121. Elevated plasma aldosterone during contraceptive therapy.
  122. Emotional factors in contraception.
  123. An empirical model for demographic evaluation of the impact of contraception and marital status on birthrates with computerized applications to the setting of targets and quotas for family planning programs.
  124. End to abortion for birth control is goal of "true" family planning.
  125. Endocrinological effects of oral contraceptives.
  126. Endometrial bacterial flora following insertion of an intrauterine contraceptive device. [La flore bacterienne endometriale apres la pose d'un contraceptif intra-uterin.]
  127. Epidemiological aspects of contraceptive sterilization: 2. Use-effectiveness, safety, reversibility and feasibility of vasectomy.
  128. Epidemiology of benign breast lesions: lack of association with oral contraceptive use.
  129. Epidemiology of reactions to contraceptive drugs.
  130. Erythema nodosum and oral contraception. (Letter to the editor)
  131. Erythema nodosum secondary to the use of oral contraceptive: a case report.
  132. Essential metals in oral contraceptive tablets.
  133. Establishing a balance between family planning services and communication activities.
  134. Estimated total cost of fertility control: (Unmet needs in family planning: a supplementary background paper for IPPF, 21st Anniversary Conference, Brighton, England, October 22-27, 1973)
  135. Estimates of the family planning program's effects on fertility in the 1970s.
  136. Estimation of norms from a controlled sample survey. II. Influence of body habitus oral contraceptives, and other factors on values for the normal range derived from the SMA 12/60 screening group of tests.
  137. Estrogens and contraceptives as thrombotic drugs: assays of thrombus formation, platelet aggregation and adhesiveness.
  138. Estrogens as post-coital contraception: a registry for effects.
  139. Ethical and religious aspects of family planning.
  140. Ethiopia (Family planning)
  141. Europe and family planning.
  142. Evaluating the effectiveness of a two-year family-planning action program at Ban Pong village, in northern Thailand.
  143. Evaluation in Bangladesh family planning program.
  144. Evaluation of contraceptive methods.
  145. Evaluation of family planning month. Study 84.
  146. Evaluation of family planning programs: presentation of a general model, and its application to the national family planning program of Malaysia. (Abstract only)
  147. Evaluation of intra-uterine contraception in selected mission hospitals in India.
  148. Evaluation of the contraceptive efficacy of quingestanol acetate in daily microdose and post coitum.
  149. Evaluation of the five-year family planning plan.
  150. Evaluation system for postcoital contraceptive methods.
  151. An evaluative look at a family planning radio campaign in Latin America.
  152. The evolution of family planning in Australia.
  153. Expected side effects of oral contraception and their management.
  154. Experience with 3 types of intrauterine device for contraception at the clinic of the Delaware League for Planned Parenthood.
  155. Experience with a contraception program in Chile. [Experiencia con un plan anticonceptivo en Chile.]
  156. Experience with abortions in a free-standing planned parenthood service.
  157. Experience with long-term contraception using Exlution. [Zkusenosti s dlouhodobou antikoncepci Exlutonem.]
  158. Experience with the 25-S double coil intrauterine contraception device (a preliminary report)
  159. Experience with tri-monthly injection of depo-medroxyprogesterone acetate as a contraceptive agent.
  160. Experts meeting on Research in Family Planning Communication, Davao City, Philippines, October 24-28, 1972: final report.
  161. Experts meeting on training of family planning communicators, final report, Honolulu, Hawaii, October 9-13, 1972.
  162. The extrapolation of experimental findings (animal to man): the dilemma of the systemically administered contraceptives.
  163. Extrauterine pregnancy as a complication of intrauterine contraception. [Vnematochnaya beremennost kak oslozhnenie pri vnutrimatochnoi kontratsep tsii.]
  164. An extrauterine pregnancy during contraceptive treatment with Depo-Provera (author's transl) [Een extra-uteriene graviditeit tijdens anticonceptie met Depo-Provera.]
  165. A factor analysis model to study variation of family planning performance in India.
  166. A factor analysis of contraceptive preferences.
  167. Factors associated with dropping out of family planning clinics in Jamaica.
  168. Factors associated with utilization of family planning clinics in Costa Rica.
  169. Factors influencing the preference of family planning method in East Java.
  170. Factors influencing the utilization of family planning nurse specialists.
  171. Fallacies in the evaluation of results of clinical trials of oral contraceptives and recommendations for the standardization of methods. [Trugschlusse bei der Auswertung von Resultaten aus klinischen Prufungen oraler Kontrazeptiva und Vorschlage zur Standardisierung der Methoden.]
  172. Family design and family planning.

     

  173. Family doctors and contraception.
  174. Family health and family planning. (Letter to the Editor)
  175. Family health versus family planning.
  176. Family health versus family planning. (Letter to the editor)
  177. Family health's complete guide to birth control.
  178. Family planning acceptors.
  179. Family planning activities.
  180. Family planning advice on television.
  181. Family planning and abortion.
  182. Family planning and cancer screening services as provided by paramedical personnel.
  183. Family planning and communication in social development.
  184. Family planning and desired family sizes.
  185. Family planning and family life: a personal experience.
  186. Family planning and fertility decline in Korea: retrospect and prospect.
  187. Family planning and indigenous medicine practitioners.
  188. Family planning and mass education.
  189. Family planning and maternal and child health care in Ghana.
  190. Family planning and medical responsibility. [Familienplanung aus arztlicher Verantwortung.]
  191. Family planning and occupational health.
  192. Family planning and population policies in developed and less developed countries.
  193. Family planning and religion.
  194. Family planning and socio-economic status.
  195. Family planning and the Australian aborigines.
  196. Family planning and the law in Australia. Part A: primary family planning legislation.
  197. Family planning and the N.H.S. (National Health Service, England)
  198. Family planning and the nurse.
  199. Family planning and the Philippine Medical Association.
  200. Family planning and the schools: a look at the planned parenthood mailbag.
  201. Family planning and the social work educator.
  202. Family planning as a human right: some jurisprudential reflections on natural rights and positive law.
  203. Family planning as it affects the status of women.
  204. Family Planning Association of India. Report 1972-1973.
  205. Family planning association of Pakistan.
  206. Family planning by mothers on welfare.
  207. Family planning by the temperature method.
  208. Family planning centers are becoming nuclei for community health facilities.
  209. Family planning centers. [Les centres d'orthogenie.]
  210. Family planning clinic at St. Peter's Albany.
  211. Family planning clinic density and the acceptance rate: evidence from the Philippines.
  212. A family planning clinic in general practice.
  213. Family planning clinics in 1970.
  214. Family planning comics in the Philippines.
  215. Family planning communications in the context of national development: communications for information and motivation in family planning.
  216. Family planning counsel.
  217. A family planning data system.
  218. A family planning data system: teaching note.
  219. Family planning developments in China, 1960-1966: abstracts from medical journals.
  220. Family planning dropouts and how to communicate with them.
  221. Family planning education and motivation for industrial workers; the role of industrial physician.
  222. Family planning education: parenthood and social disease control.
  223. The family planning effort in Egypt: a descriptive sketch.
  224. Family planning field worker performance in Thailand.
  225. Family planning field workers: sterilization and abortion. Study 78.
  226. Family planning from a worldwide point of view.
  227. Family planning in a rural nurse-midwifery program.
  228. Family planning in Africa: overcoming social and cultural resistances.
  229. Family planning in an industrial community.
  230. Family planning in Australia [editorial]
  231. Family planning in Australia. (Letter to the editor)
  232. Family planning in Australia. (Letter to the editor)
  233. Family planning in Brazil. [O planejamento familiar no Brasil.]
  234. Family planning in Canada.
  235. Family planning in Ceylon.
  236. Family planning in China.
  237. Family planning in Colombia: changes in attitude and acceptance, 1964-69.
  238. Family planning in continental sub-Saharan Africa.
  239. Family planning in five continents: Africa, America, Asia, Europe, Oceania.
  240. Family planning in home economics: [an educational packet of pamphlets and visual aids]
  241. Family planning in hospital and nonhospital settings.
  242. Family planning in India.
  243. Family planning in industry.
  244. Family planning in Israel.
  245. Family planning in Israel: irrationality and ignorance.
  246. Family planning in Japan.
  247. Family planning in Malta.
  248. Family planning in Nicaragua: country note: the demographic situation.
  249. Family planning in nursing.
  250. Family planning in social and economic development: some points for discussion.
  251. Family Planning in the "soft state."
  252. Family planning in the curricula of schools and colleges.
  253. Family planning in the education of nurses and midwives.
  254. Family planning projects in industry.
  255. Family Planning Reviews.
  256. Family planning service dispensation: procurement, storage, distribution and supplies.
  257. Family planning service expansion.
  258. Family planning services and Population Research Act.
  259. Family planning services in England and Wales.
  260. Family planning services in England and Wales.
  261. Family planning services in industry.
  262. Family planning services in industry: a survey.
  263. Family planning services in the tea plantations of Assam.
  264. Family planning services in Yugoslavia.
  265. Family planning services: an individualized approach.
  266. Family planning should utilize full variety of contraceptives.
  267. Female barrier contraceptives.
  268. Female emancipation, birth control, and fertility in European history.
  269. Female work participation and work-motivated contraception.
  270. Feminis and other vitamin-mineral supplements for women taking oral contraceptives.
  271. Fertility and family planning in Iran. [Fecondite et la planification familiale en Iran.]
  272. Fertility and family planning: an interim report on 1971 fertility-abortion survey.
  273. Fertility characteristics and family planning knowledge, attitudes, and practice in Baghdad, Iraq.
  274. Fertility inhibition with a new low-dose progestogen oral contraceptive agent.
  275. Field experiment comparing family planning education programmes directed at males and females.
  276. A field study of Depo-Provera: its use as a contraceptive method by women in a rural town in West Malaysia from February 1968 to December 1969.
  277. The field worker in IE&C support for family planning programs.
  278. Fiji. (Family planning)
  279. Fiji: a study of ethnic plurality and family planning.
  280. Filipinos assess their family planning doctors.
  281. Final report of the comparative study of the radio school of family planning of the Dominican Association for Family Welfare, Inc. [Informe final del estudio comparativo de la escuela radiofonica de educacion familiar de la Asociacion Dominicana Pro Bienestar de la Familia, Inc.]
  282. Final report to the Population Council: practical recommendations for increasing market demand for contraceptives in the private sector.
  283. A five-year plan for population research and family planning services: second progress report to the Congress of the United States, pursuant to Section 5, Public Law 91-572.
  284. Folate metabolism in women using oral contraceptive agents (OCA). (Abstract only)
  285. A formula for the 1970s: estimating need for subsidized family planning services in the United States.
  286. Four years of contraceptive service in Jakarta, 1968-1971.
  287. A framework for the design of family planning program evaluation systems.
  288. A framework for the selection of family planning program evaluation topics.
  289. Francophone courses (Family planning)
  290. Free and good: family planning in the National Health Service.
  291. Free contraception and the NHS Reorganisation Bill.
  292. Free contraception.
  293. Free contraception.
  294. Free contraceptives in Great Britain.
  295. Free contraceptives.
  296. Free-standing subsidized family planning clinics: the manpower cost of patient services.
  297. From family planning toward family welfare planning: an alternative program strategy.
  298. FSH-releasing activity throughout the normal menstrual cycle and during the use of oral contraceptives.
  299. Functional disturbances of the optic nerve during treatment with oral contraceptives. [Funktionelle Storungen des Sehnerven bei Anwendung oraler Antikonzeptiva.]
  300. Further experience with a once-a-month oral contraceptive: quinestrol-quingestanol. A follow up of a 3 year experience.
  301. Further investigations concerning bisecurin, a peroral contraceptive of low hormonal contents.
  302. Future approaches in the oral contraceptive field in developing countries.
  303. The future of federal support for family planning services and population research.
  304. Galactorrhea during oral contraception. [Wahrend der oralen Kontrazeption aufgetretene Galaktorrhoe.]
  305. A general statistical model for characterizing the growth patterns and projecting the level of performance of family planning clinics.
  306. The genesis of Family Planning Sales Limited.
  307. Genetic effects of family planning. (Letter to the editor)
  308. Genetic effects of family planning. (Letter to the editor)
  309. Genital infections in developing countries: experience in a family planning clinic.
  310. Ghana's national family planning programme: a case study of public information activities.
  311. A glossary of family planning terminology.
  312. Gonadotropic effect of sulpiride: use of a new contraceptive method. [Impact gonadotrope du sulpiride: Initiation a une nouvelle methods contr aceptive.]
  313. Government programmes and voluntary action, partnership in Planned Parenthood, statement made at the "IPPF 21" Conference, London, England, 22 October 1973.
  314. Grenada (Family planning)
  315. The growing use of sterilization for birth control.
  316. Growth and development of the Indonesian national family planning program data system.
  317. Guadalupe Family Planning Clinic (A)
  318. Guadalupe family planning clinic. (B)
  319. Guide in presenting an introductory talk to patients on family planning.
  320. Guide to steroid contraception in general practice. (Letter to the editor)
  321. A guidebook for family planning education.
  322. Guidelines to facilitate the introduction of new contraceptives into national family planning programs.
  323. Haemolytic uraemic syndrome in women taking oral contraceptives.
  324. Hair growth disorders in relation to pregnancy and hormonal contraception. [Haarwuchsstoerungen in Zusammenhang mit Schwangerschaft und hormonaler Kontrazeption.]
  325. Hair loss and contraceptives.
  326. Headaches related to contraceptive therapy and their control.
  327. Health and family planning in a Honduran barrio.
  328. Health aspects of family planning with particular reference to social development.
  329. Health aspects of oral contraceptive use.
  330. Health education in health aspects of family planning: report of a WHO study group.
  331. Health, family planning and population growth.
  332. Hepatic effects of oral contraception. [Effets hepatiques des contraceptifs oraux.]
  333. Herbs used for contraception in the Unani and other indigenous systems of medicine.
  334. Hesitations and worries of 330 couples choosing vasectomy for birth control.
  335. High and low estrogen levels in women taking hormonal contraception? [Oestrogen-uber- oder -unterversorgung der Frau bei der hormonalen Kontrazeption?]
  336. Histologic and autoradiographic studies of the human endometrium under sequential oral contraceptive conditions. [Histologische und autoradiographische Untersuchungen am Menschlichen Endometrium unter der 2-Phasen-Therapie mit Mestranol-Lynestrenol.]
  337. Histological changes in ovarian and uterine blood vessels after the use of oral contraceptive agents (estrogen-gestagen combinations) and gestagens.
  338. The histological picture of endometrium-material following prolonged use of oral contraceptives. (Abstract only)
  339. The history and present position of family planning in Japan.
  340. Home visits with groups of women "ready" for family planning.
  341. Hormonal contraception with a single monthly dosage. [Anticoncepcion hormonal con una dosis unica mensual.]
  342. Hormonal contraceptives - psychosomatic aspects. [Hormonale Kontrazeptiva-psychosomatische Aspekte.]
  343. Hormonal contraceptives and high blood pressure (author's transl. [Anticonceptivos hormonales e hipertension.]
  344. Hospital family planning service in Khartoum, Sudan.
  345. Hospital family planning: termination of pregnancy and contraceptive use.
  346. How a pharmaceutical manufacturer introduces a new contraceptive method.
  347. How best could radio spearhead population and family planning awareness among the peasantry.
  348. How much do family planning programs cost?
  349. Hyaluronidase and its relationship to contraceptive development.
  350. An ideal contraceptive mix for planning future contraceptive programs in developing countries.
  351. Ideal versus actual: patterns of interpersonal communication in family planning in an Indian village.
  352. Ideals, motives and attitudes toward the number of children and the use of contraceptives. [Ideales, motivos y actitudes hacia el numero de hijos y el uso de anticonceptivos.]
  353. The identification and training of Traditional Birth Attendants including motivation for family planning.
  354. Identification and utilization of local leadership in family planning programmes in an urban set-up.
  355. IE&C in the commercial marketing of contraceptives.
  356. IE&C through non-governmental family planning agencies.
  357. Illicit contraception.
  358. Impact of family planning programs upon fertility.
  359. The impact of hormonal contraceptive therapy on a community and effects on cytopathology of the cervix.
  360. The impact of law on family planning in Australia.
  361. Impairment of glucose tolerance by dietary Vitamin B6 deficiency in oral contraceptive users. (Abstract only)
  362. Implants seen as reversible contraceptives.
  363. Implementation of family planning programs in an industrial set-up.
  364. The importance of the "soft dimensions" in training for family planning program management.
  365. Impressions of the Louisiana family planning program.
  366. Improved management of family planning and population programs.
  367. Improving sales and acceptance of contraceptives.
  368. In-hospital family planning. An approach to rural maternal health care.
  369. In-hospital postpartum approach to family planning.
  370. Inaugural address. (Family planning)
  371. Incentives and family planning.
  372. Incidence of abortion, fertility and contraception in Latin America.
  373. The Indian family planning programme and differential family planning performance of Indian states.
  374. Indian subcontinent (Family planning programs)

     

  375. Indian teenagers go for family planning.
  376. Indonesia (Family planning)
  377. Indonesia's family planning delivery system: a preliminary multivariate statistical inquiry.
  378. Indonesian 'Bidans' achieve a family planning "miracle".
  379. The Indonesian Family Planning Program through charts.
  380. Industry and family planning: some case studies.
  381. Influence of contraceptive therapy on the circadian patterns of blood cortisol and TSH levels.
  382. Influence of dietary lipids on plasma and hepatic lipids and on blood clotting properties in rats fed oral contraceptives.
  383. Influence of hormonal contraceptives on carbohydrate and lipid metabolism in the rat.
  384. Influence of institutional and convenience factors in the acceptance of postpartum family planning. [Influencia de factores institucionales y de conveniencia en la acceptacion de planificacion familiar en el post-parto.]
  385. The influence of long-term oral contraception on blood sugar and serum insulin. [Der Einfluss der Pillenlangzeiteinnahme auf Blutzucker und Seruminsulin.]
  386. The influence of oral contraceptive steroids on lipid metabolism.
  387. Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women.
  388. Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women.
  389. Influence of oral contraceptives on endometrial glands.
  390. The influence of oral contraceptives on the effect of low-protein-high-sucrose or low-protein-high-starch diets on male rats. (Abstract only)
  391. Influence of pregnancy and oral contraceptives on platelets in relation to coagulation and aggregation.
  392. The influence of recent use of an oral contraceptive on early intrauterine development.
  393. Information campaigns and the growth of family planning in Colombia.
  394. Information, education, and communication in Taiwan's family planning program.
  395. Injectable contraceptives in family planning: clinical experience in 14,958 cycles.
  396. Injectable contraceptives. Ten years of clinical experience. [Anticonceptivos inyectables. Diez anos de experiencia clinica.]
  397. Inspection and control of contraceptives at Apotekens centrallaboratorium.
  398. Integrating research materials development and training into one project: an innovation in family planning communication strategy.
  399. The integration of family planning and maternal-child health programs in rural areas: a program for Bangladesh.
  400. Integration of family planning with maternal and child health, nutrition and general health services.
  401. Integration of health and family planning program.
  402. Interactions of nutrients with oral contraceptives and other drugs.
  403. Interdigitation of mental health and family planning services.
  404. The International Planned Parenthood Federation (IPPF)
  405. International study of oral contraceptives 1968-1972: (Report prepared for the Population INformation Program)
  406. Intestinal infarct during treatment with oral contraceptives. [Su un caso di infarto intestinale in corso di terapia con anticoncezionali orali.]
  407. Intrauterine contraception in nulliparas with the Dalkon Shield.
  408. Intrauterine contraception.
  409. Intrauterine contraception. [Contraception intra-uterine.]
  410. Intrauterine contraceptive device and increased serum immunoglobulin levels.
  411. Intrauterine contraceptive devices.
  412. Intrauterine contraceptive devices.
  413. Intrauterine contraceptive devices. (Letter to the editor)
  414. Intrauterine devices: contraceptives or abortifacients? [Dispositivos intra-uterinos: contraceptivos ou abortivos?]
  415. Intravaginal ring for steroid contraception.
  416. Introduction to oral contraception.
  417. Introduction. (Teaching family planning)
  418. Investigations of the potential genetic effects of hormonal contraceptives.
  419. Involving the commercial sector in family planning programs.
  420. Is it illegal to supply oral contraceptives to minors? [Er det en overtraedelse af straffeloven at give p-piller til mindrearige?]
  421. Is the use of oral progestogens an essential component of clinical programs in family planning?
  422. Ischaemic cerebrovascular disease in young adults. 1. Smoking habits, use of oral contraceptives, relative weight, blood pressure and electrocardiographic findings.
  423. Issues and problems in the administration of family planning programme and policy.
  424. Issues and problems that confront nursing in delivering family planning services.
  425. Jamaica's mass media campaign: a case study of a public information program for family planning.
  426. Kenya's population and family planning policy: a challenge to development communication.
  427. Keynote address. (Family Planning in Trinidad and Tobago)
  428. The Kinga contraceptive marketing project: progress report no. 5.
  429. Knowledge and use of family planning methods. [Conocimiento y uso de metodas de planificacion familiar conocimiento de metodos.]
  430. Knowledge of contraceptive methods in a rural area (India)
  431. Knowledge of school teachers about family planning and their reactions to a population education curriculum.
  432. Knowledge, attitude and practice of contraception in Ibadan.
  433. Korea (Planned Parenthood Federation)
  434. Korea's family planning program gets high marks.
  435. La contraception en medecine generale. Problemes techniques, educatifs et sociologiques du planning familial. (Contraception in general medicine. Technical, educational, and sociological problems of family planning.)
  436. La contraception hormonale. (Hormonal contraception.)
  437. La detection des effets genetiques de la contraception. (Detection of genetic effects of contraception.)
  438. Lack of uterotrophic effect of an intrauterine contraceptive suture in estrogen primed rat.
  439. Laparoscopic removal of an intrauterine contraceptive device in an oral contraceptive user.
  440. Laser induced microvascular thrombosis in mice treated with oral contraceptives.
  441. Latin American family planning in the 1970s.
  442. A Latin American field trial with a once-a-month oral contraceptive.
  443. Law and family planning in Bangladesh.
  444. The law relating to birth control.
  445. The League and birth Control.
  446. Legal abortion as a positive mental health measure in family planning.
  447. Legal abortion: a method of family planning.
  448. Legal abortions and preventive birth control in Sweden 1968-72. [Legala aborter och preventiv fodelsekontroll i Sverige under perioden 19 68-72.]
  449. Legal aspects of family planning. [Aspectos legais do planejamento familiar.]
  450. Legalized abortion in family planning programme.
  451. Legislation of abortion and family planning.
  452. Life table analysis of a clinical study of a once-a-month oral steroid contraceptive: quinestrol-quingestanol.
  453. Limitations of the "continuation rate" as a measure of family planning program performance.
  454. Link inflammatory cells, IUD's contraceptive effect.
  455. Lipid implications during Ovral contraception.
  456. Liver function tests following longterm intake of oral contraceptives. [Leberfunktionsuntersuchungen nach langfristiger Einnahme kontrazeptiver Medikaments.]
  457. Long-term contraception with the lynestrenol "mini-pill."
  458. Long-term use of oral contraceptives: a study of chromosomes and lymphocyte transformation.
  459. Longitudinal study of the effects of oral contraceptives on human chromosomes.
  460. The Louisiana family planning program.
  461. The Louisiana Family Planning Program: an analysis of a statistical analysis.
  462. Low dosage progestagen as an oral contraceptive: a clinical study.
  463. Low-dose lynestrenol as a contraceptive method.
  464. Low-oestrogen combined oral contraceptive.
  465. LRF antagonists could be used in new contraceptives.
  466. Lyndiol, a new low-dose oral contraceptive. [Lyndiol, ein niedrig dosiertes orales Kontrazeptivum.]
  467. A mail questionnaire to doctors on the extent of contraceptive advice and practice. Study 23.
  468. Malaysia (Family planning communication program)
  469. Malaysia's family planning programme assisted.
  470. Male attitudes to family planning in a special community. Study 24.
  471. Male attitudes: contraception is job of both partners.
  472. Male chemical contraceptive development.
  473. Male contraception by androgen blockade.
  474. Male sterilization as a contraceptive method in Canada: an empirical study.
  475. Mali. (Family planning)
  476. Mammograms in women on oral contraceptives. [Das Mammogramm unterkontrazeptiva.]
  477. Management and family planning programs: Indonesia, a country profile.
  478. The management bottleneck in family planning programs.
  479. Management motivation in family planning.
  480. Management of oral contraception in "problem" patients.
  481. Management of the patient receiving oral contraception.
  482. The management problem in national family planning programs: the IBRD approach.
  483. Management problems of family planning programs in the Philippines.
  484. Manpower for family planning services.
  485. The marital and sexual adjustment of 330 couples who chose vasectomy as a form of birth control.
  486. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy.
  487. Marketing and family planning program management.
  488. Marketing and market research in family planning.
  489. Marketing birth control.
  490. A marketing perspective of family planning.
  491. Maryland pharmacists ready for family planning initiative.
  492. Mass media in family planning and development: a manual.
  493. The maternal and child health/family planning training and research center.
  494. Maternal health, child health and family planning: a plea for integrated approach.
  495. Maternal nutrition: a positive approach in family planning.
  496. Mauritius. (Family planning)
  497. The McCracken County Family Planning Program: project report.
  498. Measuring effectiveness in family planning.
  499. Mechanism of action of the pill-a-month and mini-dose oral contraceptives. (Abstract only)
  500. Mechanism of hypertriglyceridaemia associated with contraceptive steroids.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.